{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:05:32Z","timestamp":1762981532870,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.carrev.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T19:38:21Z","timestamp":1673897901000},"page":"8-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3\u2122 Cerebral Embolic Protection Device"],"prefix":"10.1016","volume":"50","author":[{"given":"Sayonara M.","family":"Daal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian M.J.","family":"Jimenez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"Voskuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan O.","family":"Kraaijeveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Dessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiz Z.","family":"Ramjankhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa M.","family":"Mokhles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter R.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2023.01.008_bb0005","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1097\/MJT.0000000000001413","article-title":"Risk of stroke after transcatheter aortic valve implantation: epidemiology, mechanism, and management","volume":"28","author":"Ciobanu","year":"2021","journal-title":"Am J Ther"},{"key":"10.1016\/j.carrev.2023.01.008_bb0010","first-page":"95","article-title":"Transcatheter aortic valve replacement and stroke: a comprehensive review","volume":"15","author":"Davlouros","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.carrev.2023.01.008_bb0015","first-page":"9","article-title":"Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (placement of aortic transcatheter valves)","author":"Kapadia","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.01.008_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","article-title":"Protection against cerebral embolism during transcatheter aortic valve replacement","volume":"69","author":"Kapadia","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2023.01.008_bb0025","first-page":"9","article-title":"Neurological events following transcatheter aortic valve replacement and their predictors: a report from the CoreValve trials","author":"Kleiman","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.01.008_bb0030","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2023.01.008_bb0035","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2023.01.008_bb0040","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jcin.2015.01.020","article-title":"Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation","volume":"8","author":"Van Mieghem","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.01.008_bb0045","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jacc.2018.07.093","article-title":"Neurological complications after transcatheter versus surgical aortic valve replacement in intermediate-risk patients","volume":"72","author":"Durko","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2023.01.008_bb0050","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jcin.2020.05.039","article-title":"Ischemic stroke with cerebral protection system during transcatheter aortic valve replacement","volume":"13","author":"Megaly","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.01.008_bb0055","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/CIRCULATIONAHA.112.110981","article-title":"Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation","volume":"126","author":"Nombela-Franco","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2023.01.008_bb0060","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2019.7525","article-title":"Association between transcatheter aortic valve replacement and early postprocedural stroke","volume":"321","author":"Huded","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2023.01.008_bb0065","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/eurheartj\/ehab213","article-title":"A randomized evaluation of the TriGuard HDH cerebral embolic protection device to reduce the impact of cerebral embolic LEsions after TransCatheter aortic valve ImplanTation: the REFLECT I trial","volume":"42","author":"Lansky","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2023.01.008_bb0070","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehv191","article-title":"A prospective randomized evaluation of the TriGuard HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial","volume":"36","author":"Lansky","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2023.01.008_bb0075","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.4244\/EIJ-D-19-00741","article-title":"A pilot study with the TriGUARD 3 cerebral embolic protection device","volume":"16","author":"Magalhaes","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2023.01.008_bb0080","first-page":"470","article-title":"TriGuard\u2122 HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement","volume":"89","author":"Samim","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.01.008_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcin.2020.11.011","article-title":"Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II","volume":"14","author":"Nazif","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.01.008_bb0090","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/CIRCULATIONAHA.120.052874","article-title":"Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the transcatheter valve therapy registry","volume":"143","author":"Butala","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2023.01.008_bb0095","first-page":"959","article-title":"Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: a US nationwide study","volume":"98","author":"Khan","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.01.008_bb0100","article-title":"Safety and efficacy of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: a meta-analysis of in-hospital outcomes","author":"Shimamura","year":"2021","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.carrev.2023.01.008_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.carrev.2021.05.010","article-title":"Cerebral embolic protection during transcatheter aortic valve replacement","volume":"36","author":"Yashima","year":"2022","journal-title":"Cardiovasc Revasc Med"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:25:48Z","timestamp":1761560748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838923000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":21,"alternative-id":["S1553838923000106"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2023.01.008","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3\u2122 Cerebral Embolic Protection Device","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}